(Press-News.org) Glenview, Illinois – The American College of Chest Physicians® (CHEST) recently released a new clinical guideline on antithrombotic therapy in arterial thrombosis andthromboembolism in COVID-19. Published in the journal CHEST®, the guideline contains 11 evidence-based recommendations to improve risk-evaluation and to assist in determining the course of treatment.
While there are guidelines for the management of COVID-19-related coagulopathy for venous thromboembolism (VTE), a recent large cohort study showed that COVID-19 was associated with substantially increased incidence of both VTE and arterial thromboses, including myocardial infarction and stroke.
“The new guideline provides recommendations for managing four arterial (pro)thrombotic medical conditions so that when a patient presents with COVID-19 infection either with an acute thrombotic event or a history of them, the clinician will be able to assess the risks and benefits of administering additional medication that may interact with a current antithrombotic, as well as the need for modification of current antithrombotic therapy,” says Tatjana Potpara, MD, PhD, FESC, lead author on the guideline. “By addressing these interactions and risks in a guideline, we can better prepare clinicians to make informed decisions on their treatment plan and standardize care.”
The guideline includes the conditional recommendations relating to:
1) acute coronary syndrome/percutaneous coronary intervention,
2) a history of or acute stroke or transient ischemic attack,
3) previously known or newly diagnosed atrial fibrillation, and
4) peripheral artery disease/acute limb ischemia.
The recommendations include:
In hospitalized patients with COVID-19 and confirmed acute coronary syndrome (ACS), we recommend dual antiplatelet therapy to reduce the risk of recurrent ACS or death.
In outpatients with COVID-19 receiving antiplatelet therapy for a previous stroke, we suggest against the addition of or change to oral or subcutaneous anticoagulation.
In hospitalized patients with COVID-19, not in the ICU, receiving oral anticoagulation for atrial fibrillation in whom the discontinuation of oral anticoagulation is needed during hospitalization, we suggest switching over to therapeutic dose LMWH or unfractionated heparin.
In hospitalized patients with COVID-19 and stable peripheral artery disease (i.e., no acute limb events or revascularization procedures within the past 30 days), we suggest continuation of antiplatelet therapy if concurrent prophylactic-dose anticoagulation for COVID-19 is being given.
The existing evidence and panel consensus do not suggest a major departure from the management of arterial thrombosis as per pre-COVID-19 recommendations. Data on the optimal strategies for prevention and management of arterial thrombosis and thromboembolism in patients with COVID-19 are sparse, and more high-quality evidence is needed to inform management strategies in these patients.
The entire list of recommendations included in the new guideline can be accessed through the CHEST journal website.
About the American College of Chest Physicians
The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.
END
CHEST releases clinical practice guideline on antithrombotic therapy in arterial thrombosis and thromboembolism in COVID-19
2023-06-29
ELSE PRESS RELEASES FROM THIS DATE:
UTHSC College of Pharmacy rises to No. 6 in research funding from National Institutes of Health
2023-06-29
The College of Pharmacy at the University of Tennessee Health Science Center is now ranked No. 6 in annual research funding from the National Institutes of Health, according to a new listing published by the American Association of Colleges of Pharmacy of its approximately 140 member institutions.
“The ranking of No. 6 in NIH funding for federal fiscal year 2022 is external validation for the UTHSC College of Pharmacy’s standing as one of the leading institutions in research among the 142 U.S. pharmacy schools,” said Bernd Meibohm, ...
New single-photon Raman lidar can monitor for underwater oil leaks
2023-06-29
WASHINGTON — Researchers report a new single-photon Raman lidar system that operates underwater and can remotely distinguish various substances. They also show that the new system can detect the thickness of the oil underwater up to 12 m away, which could be useful for detecting oil spills.
“Differentiating substances in water and detecting their distribution characteristics in the ocean are of great significance for marine monitoring and scientific research,” said research team leader Mingjia Shangguan from Xiamen University in China. “For instance, the remote sensing of underwater oil that we ...
Faster, safer target prep
2023-06-29
Oak Ridge National Laboratory researchers have developed a method to simplify one step of radioisotope production — and it’s faster and safer.
ORNL produces several radionuclides from irradiated radium-226 targets, including actinium-227 and thorium-228, both used in cancer treatments. Continuously improving isotopes for human health is one of the lab’s missions.
Currently, it takes workers two weeks to prepare radium-226 targets for irradiation in the High Flux Isotope Reactor. The targets are exposed to radiation throughout the process, which involves pressing radium carbonate aluminum composite into 10 pellets — one each day — and sealing ...
Health care utilization following interventions to improve social well-being
2023-06-29
About The Study: This systematic review and meta-analysis including 41 studies and 7,800 participants found that psychosocial interventions were associated with decreased health care use in most health services and increased use of outpatient care. The greatest health care decrease was among caregivers and individuals with mental illnesses and in interventions delivered 1-on-1 by health professionals.
Authors: Neta HaGani, M.S.W., of the University of Sydney in Sydney, Australia, is the corresponding author.
To ...
Transferring data with many colors of light simultaneously
2023-06-29
New York, NY—June 29, 2023—The data centers and high-performance computers that run artificial intelligence programs, such as large language models, aren’t limited by the sheer computational power of their individual nodes. It’s another problem — the amount of data they can transfer among the nodes — that underlies the “bandwidth bottleneck” that currently limits the performance and scaling of these systems.
The nodes in these systems can be separated by more than one kilometer. Since metal wires dissipate electrical signals as heat when transferring data at high speeds, these systems transfer data via fiber-optic ...
An early predictor of cognitive decline in Parkinson’s disease
2023-06-29
Have you ever felt the strong sensation that someone is behind you, so intense that you turn around, only to see that no-one is there? This is a 'presence hallucination’. Presence hallucinations are particularly frequent but underreported in patients with Parkinson’s disease and may appear early on in the course of the disease. They are sometimes ignored by the patient, by clinicians, or brushed off as a simple side-effect of medication.
Now, EPFL scientists have found that patients recently diagnosed with Parkinson’s disease and who have early hallucinations are ...
Cracking the tubulin code
2023-06-29
Tubulin is a protein that plays a crucial role in the structure and function of cells. It is the main component of microtubules, which are long, hollow fibers that provide structural support, help the cell divide, give it its shape, and act as tracks for moving molecular cargo around inside the cell.
There are two types of tubulin: alpha-tubulin and beta-tubulin. Together, they form dimeric (two-part) building blocks, spontaneously assembling into microtubules that undergo further continuous cycles of assembly and disassembly.
The tubulin code
To fine-tune microtubules, the dimers undergo various post-translational modifications (PTMs), which are chemical modifications that occur ...
Amander T. Clark takes on new role as President of the ISSCR
2023-06-29
Skokie, IL – The ISSCR is pleased to announce Amander T. Clark, PhD, Professor of Molecular, Cell and Developmental Biology, University of California, Los Angeles (UCLA), USA, as its President. Dr. Clark’s one-year term of office leading the global society begins 1 July 2023.
“I will work to ensure that the society continues to defend stem cell science and the researchers working to transform lives,” Dr. Clark said at the ISSCR 2023 Annual Meeting in Boston this month. “We will expand our engagement with the public ...
New AI tool beats standard approaches for detecting heart attacks
2023-06-29
A new machine learning model uses electrocardiogram (ECG) readings to diagnose and classify heart attacks faster and more accurately than current approaches, according to a study led by University of Pittsburgh researchers that published today in Nature Medicine.
“When a patient comes into the hospital with chest pain, the first question we ask is whether the patient is having a heart attack or not. It seems like that should be straightforward, but when it’s not clear from the ECG, it can take ...
Proteins predict significant step toward development of diabetes
2023-06-29
RICHLAND, Wash.—Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.
In a paper published online on June 29 in Cell Reports Medicine, researchers at the Department of Energy’s Pacific Northwest National Laboratory and their colleagues identify a set of altered proteins that predict a condition known as islet autoimmunity, a precursor for everyone who will ultimately develop Type 1 diabetes.
The scientists caution that the work marks a beginning, not the end, of a search for a way to predict who will develop the disease. More work needs to be done ...